brigatinib (Alunbrig)

brigatinib · Takeda

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for brigatinib (Alunbrig), covering 2025-01-23 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors [Phase 1, Phase 2]